Ribeiro U, Whiteside T L, Basse P H, Safatle-Ribeiro A V, Huneke C E, Posner M C
University of Pittsburgh, The University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA.
J Surg Res. 1999 Mar;82(1):78-87. doi: 10.1006/jsre.1998.5521.
Adoptively transferred activated natural killer (A-NK) cells are capable of selectively infiltrating solid tumors, but only at low efficiency when administered systemically. It is unclear if human A-NK cells can be retained in tumor tissue and, if so, what is their action. We investigated intratumor A-NK cell retention and in situ cytokine production, using an xenogeneic ex vivo tissue-isolated tumor model, which permits direct intraarterial infusion.
Human colon adenocarcinoma (HT-29) was implanted in the ovarian fat pad of nude rats. The tumors were perfused ex vivo 25 to 30 days postimplant with a known number of cells, and the effluent was collected over time. The number of human A-NK cells and cell surface antigen expression of cells infused and exiting the tumor were calculated, using cell counts and flow cytometry, respectively. Frozen sections were stained with Giemsa and also immunostained for the presence of interleukin-2, -4, and -10, tumor necrosis factor alpha (TNF-alpha), and interferon.
Six perfusions with 8 x 10(6) A-NK cells were performed. The mean number of infused A-NK cells that remained in the tumor at the completion of perfusion was 4.74 x 10(6) (59.2%). No differences were noted in cellular phenotype between the infused cells and the cells exiting the tumor: expression of the markers CD45 (97.5% vs 94. 5%), CD14 (0 vs 0), CD3 (3.83% vs 2.83%), and CD56 (86% vs 83%) was unchanged, P > 0.05. Microscopic examination of tumor sections showed tumor surrounded by A-NK cells, with some tumor nests infiltrated by A-NK cells. In situ immunopositivity for interleukin-2 (2/6), interleukin-4 (3/6), interleukin-10 (2/6), and TNF-alpha (2/6) specimens was observed. Immunostaining for interferon-gamma was negative. Conclusions. The retention of A-NK cells in the transplanted human colon tumor tissue was found to be efficient (59.2 %) in this model. Although perfusion time was limited, A-NK cells were able to infiltrate the tumor and initiate cytokine production.
过继转移的活化自然杀伤(A-NK)细胞能够选择性地浸润实体瘤,但全身给药时效率较低。目前尚不清楚人A-NK细胞是否能在肿瘤组织中留存,若能留存,其作用又是什么。我们使用一种异种体外组织分离肿瘤模型(该模型允许直接动脉内灌注),研究肿瘤内A-NK细胞的留存情况及原位细胞因子的产生。
将人结肠腺癌(HT-29)植入裸鼠的卵巢脂肪垫。在植入后25至30天对肿瘤进行离体灌注,灌注已知数量的细胞,并随时间收集流出液。分别使用细胞计数和流式细胞术计算灌注和流出肿瘤的人A-NK细胞数量及细胞表面抗原表达。冰冻切片用吉姆萨染色,并进行免疫染色以检测白细胞介素-2、-4和-10、肿瘤坏死因子α(TNF-α)及干扰素的存在情况。
进行了6次用8×10⁶个A-NK细胞的灌注。灌注结束时留在肿瘤内的灌注A-NK细胞平均数量为4.74×10⁶个(59.2%)。灌注细胞与流出肿瘤的细胞在细胞表型上无差异:标志物CD45(97.5%对94.5%)、CD14(0对0)、CD3(3.83%对2.83%)和CD56(86%对83%)的表达未改变,P>0.05。肿瘤切片的显微镜检查显示肿瘤被A-NK细胞包围,一些肿瘤巢被A-NK细胞浸润。观察到白细胞介素-2(2/6)、白细胞介素-4(3/6)、白细胞介素-10(2/6)和TNF-α(2/6)标本的原位免疫阳性。干扰素-γ免疫染色为阴性。结论:在该模型中发现A-NK细胞在移植的人结肠肿瘤组织中的留存效率较高(59.2%)。尽管灌注时间有限,但A-NK细胞能够浸润肿瘤并启动细胞因子的产生。